Eptifibatide is associated with significant cost savings and similar clinical outcomes to abciximab when used during primary percutaneous coronary intervention for ST-elevation myocardial infarction: An observational cohort study of 3863 patients

INTRODUCTION: Glycoprotein IIb/IIIa inhibitors are recommended by guidelines in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. There are few studies directly comparing these agents. The aim of this study was to assess whether eptifib...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JRSM Cardiovasc Dis
Main Authors: Rathod, KS, Antoniou, S, Avari, P, Ding, N, Wright, P, Knight, C, Jain, AK, Mathur, A, Smith, EJ, Weerackody, R, Wragg, A, Jones, DA
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2017
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5637964/
https://ncbi.nlm.nih.gov/pubmed/29051816
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2048004017734431
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados